Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Gemina Laboratories Ltd Ordinary Shares C.GLAB

Alternate Symbol(s):  GMNLF

Healthcare Biotechnology
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. It endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (CSE:GLAB)

Fundamentals Snapshot (CSE:GLAB)

Current News (CSE:GLAB)

Gemina Laboratories to Host Investor Webinar on March 30, 2023

Accesswire 5 days ago

Gemina Labs Appoints Diagnostic Strategist Martha Najib to the Board

Accesswire March 7, 2023

Gemina Labs Announces Appointment of Healthcare Industry Leader Dr. Bola Grace to The Board of Directors

Accesswire January 25, 2023

Gemina Labs Appoints Top Ranked UK Analyst and Scientist, Dr. Stefan Hamill as Vice President, Strategy

Accesswire January 23, 2023

Gemina Labs Strategic Update: Respiratory Infections the Immediate Focus and New Strategic Partnerships on the Horizon

Accesswire January 10, 2023

Gemina Labs Completes Influenza A/B Diagnostic Test Prototype

Accesswire January 6, 2023

Gemina Labs Appoints Dr Michael Shannon as Chair of Clinical Advisory Board

Accesswire December 20, 2022

Gemina Labs Announces Research Collaboration on Next Generation Biosensors

Accesswire December 19, 2022

Gemina's Recent Investment into RAPIvD Sees Immediate Progress

Accesswire December 13, 2022
View More News ››

Opinion & Analysis (CSE:GLAB)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:GLAB)

Be the first to post on this bullboard.

Good Natured Products Inc.

Good Natured Products Inc.

Good Natured Products Inc is engaged in the design, production, and distribution of high-performance bioplastics for use in ...
View More »